Skip to main content
Clinical Trials/ISRCTN95403112
ISRCTN95403112CompletedNot Applicable

Colorectal cancer screening by quantitative analysis of DNA isolated from exfoliated cells sampled from the surface of human rectal mucosa: A case-control study

Colonix Medical Ltd (UK)0 sites170 target enrollmentStarted: July 16, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
170

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Case group: Consecutive patients (both males and females) with clinical diagnosis of colorectal malignancies recruited by Colorectal Surgery Department of the John Radcliffe Hospital (Oxford, UK)
  • 2. Control group: Clinically healthy volunteers (both males and females), age 50-70, recruited by Honiton Hospital (Honiton, UK)

Exclusion Criteria

  • 1. For both case and control groups: Extensive surgical interventions in the colorectal region or colorectal malignancies in the past
  • 2. For control group: Chronic colorectal conditions (even asymptomatic)

Investigators

Sponsor
Colonix Medical Ltd (UK)

Similar Trials